Adma Biologics (ADMA) Non-Current Deferred Revenue (2015 - 2026)
Adma Biologics (ADMA) reported Non-Current Deferred Revenue of $1.3 million for Q3 2026, down 9.9% from $1.44 million a year earlier and down 2.8% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Non-Current Deferred Revenue (2015 - 2026) Analysis & Trends
At the end of FY2025, Adma Biologics posted Non-Current Deferred Revenue of $1.41 million, down 9.2% from FY2024.
- Non-Current Deferred Revenue has declined for ten consecutive years, with a five-year compound annual growth rate of -7.9% (FY2020 to FY2025).
- By year, Non-Current Deferred Revenue came in at $1.55 million in FY2024 (-8.5%), $1.69 million in FY2023 (-7.8%), $1.83 million in FY2022 (-7.2%) and $1.98 million in FY2021 (-6.7%).
- The Q3 2026 figure ranks as the lowest quarterly Non-Current Deferred Revenue in data going back to Q4 2015.
- Year over year, Non-Current Deferred Revenue has now declined in each of the last 21 quarters, with an average decline of 9.1% over the last eight quarters.
- Over the past five years, the year-over-year decline in Non-Current Deferred Revenue ranged from 6.7% (Q4 2021) to 9.9% (Q3 2026).
- Per Business Quant data, the three quarters before Q3 2026 came in at $1.33 million (Q2 2026), $1.37 million (Q1 2026) and $1.41 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.30 Mn |
| Jun 30, 2026 | 1.33 Mn |
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 1.41 Mn |
| Sep 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 1.62 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 1.69 Mn |
| Sep 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | 1.76 Mn |
| Mar 31, 2023 | 1.80 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Sep 30, 2022 | 1.87 Mn |
| Jun 30, 2022 | 1.90 Mn |
| Mar 31, 2022 | 1.94 Mn |
| Dec 31, 2021 | 1.98 Mn |
API Access
Adma Biologics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();